H2o Therapeutics announced on 20 November it has received 510(k) marketing clearance from the US Food and Drug Administration for its prescription mobile app Parky to monitor Parkinson’s disease symptoms such as tremors and dyskinesia using the Apple Watch.
The app leverages the movement disorder API, a tool developed by Apple Inc. This comes after Apple published the results of a study of 343 participants with Parkinson’s...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?